Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2017-02-27 Interim / Quarterly Rep…
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Appendix 4D and Half Year Accounts 26 pages 480.1KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4D RESULTS FOR ANNOUNCEMENT TO THE MARKET FOR THE HALF YEAR ENDED 31 DECEMBER 2016' and contains detailed financial results for the half year ended 31 December 2016, including revenue, net loss, net tangible assets, and operational reviews. It references the Interim Financial Report for the half year ended 31 December 2016 and includes sections such as Directors' Report, Independent Auditor’s Declaration, and financial statements (Profit or Loss, Financial Position, Cash Flows, Notes). The document length is 15,000 characters, indicating it is a substantive report rather than a brief announcement. The content and structure align with an Interim / Quarterly Report, which covers a period shorter than a full fiscal year and contains actual financial statements and analysis. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). H1 2017
2017-02-27 English
MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCE 2 pages 76.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Cellmid Limited regarding the allowance of a European patent for a midkine treatment of alopecia. It discusses the patent approval status, intellectual property rights, and business implications. There is no financial data, no detailed report content, no management discussion, or earnings information. The document is relatively short (3929 characters) and serves as a news announcement about a patent allowance, which is a regulatory or corporate update rather than a financial or management report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a report publication announcement since it does not mention the release of a report. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2017-02-06 English
CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWED 2 pages 92.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Cellmid Limited regarding the allowance of a US patent for a midkine treatment of alopecia. It discusses the patent details, intellectual property portfolio, and potential clinical applications. There is no financial data, no mention of earnings, no management changes, no voting results, no regulatory certifications, or other report types. The document is a corporate announcement about intellectual property and patent status, which fits best under a general regulatory announcement category. It is not a report, presentation, or financial filing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2017-01-30 English
Appendix 4C 7 pages 2.2MB
Regulatory Filings
2017-01-23 English
Change of Director's Interest Notice - Halasz 3 pages 279.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the change (on-market trade), and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3706 characters, which is consistent with a detailed notice of director's share transactions rather than a full financial report or announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2017-01-17 English
CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMME 3 pages 99.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Cellmid Limited regarding the receipt of an Australian Government grant to support a research collaboration for their midkine programme. It details the grant amount, the purpose of the funding, the research collaboration, and background on the scientific program. There are no financial statements, no quarterly or annual financial results, no management discussion of financial performance, no voting results, no board changes, no legal proceedings, no merger or acquisition activity, and no regulatory certifications. The document is a corporate announcement about a government grant and research collaboration, which fits best under a general regulatory announcement category. It is not a report or financial filing but an announcement of a material event relevant to investors and the market. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (7876 characters) and content confirm it is a full announcement, not a brief report publication notice or certification.
2017-01-17 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.